A detailed history of Geneos Wealth Management Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 58,034 shares of MDT stock, worth $4.72 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
58,034
Previous 46,464 24.9%
Holding current value
$4.72 Million
Previous $3.66 Million 42.85%
% of portfolio
0.2%
Previous 0.16%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.84 - $91.03 $889,038 - $1.05 Million
11,570 Added 24.9%
58,034 $5.22 Million
Q2 2024

Jul 23, 2024

SELL
$78.71 - $87.02 $952,076 - $1.05 Million
-12,096 Reduced 20.66%
46,464 $3.66 Million
Q1 2024

May 03, 2024

SELL
$82.84 - $88.09 $80,686 - $85,799
-974 Reduced 1.64%
58,560 $5.1 Million
Q4 2023

Jan 26, 2024

SELL
$69.43 - $83.43 $1.19 Million - $1.43 Million
-17,131 Reduced 22.35%
59,534 $4.9 Million
Q3 2023

Oct 11, 2023

BUY
$78.22 - $90.4 $182,721 - $211,174
2,336 Added 3.14%
76,665 $6.01 Million
Q2 2023

Aug 08, 2023

BUY
$79.47 - $91.38 $1.07 Million - $1.23 Million
13,435 Added 22.06%
74,329 $6.55 Million
Q1 2023

Apr 25, 2023

BUY
$76.72 - $87.58 $4.16 Million - $4.75 Million
54,221 Added 812.54%
60,894 $4.91 Million
Q4 2022

Jan 30, 2023

BUY
$76.18 - $87.74 $50,812 - $58,522
667 Added 11.11%
6,673 $518,000
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $246,691 - $291,172
-3,055 Reduced 33.72%
6,006 $485,000
Q2 2022

Jul 22, 2022

BUY
$87.4 - $113.09 $13,459 - $17,415
154 Added 1.73%
9,061 $813,000
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $262,815 - $293,648
-2,613 Reduced 22.68%
8,907 $988,000
Q4 2021

Feb 09, 2022

SELL
$99.53 - $127.75 $23,489 - $30,149
-236 Reduced 2.01%
11,520 $1.19 Million
Q3 2021

Nov 09, 2021

BUY
$122.75 - $135.17 $23,445 - $25,817
191 Added 1.65%
11,756 $1.5 Million
Q2 2021

Jul 08, 2021

SELL
$118.19 - $131.5 $1.86 Million - $2.07 Million
-15,704 Reduced 57.59%
11,565 $1.47 Million
Q1 2021

Jun 17, 2021

SELL
$111.18 - $119.74 $667 - $718
-6 Reduced 0.02%
27,269 $3.57 Million
Q4 2020

May 19, 2021

BUY
$100.57 - $117.14 $1.15 Million - $1.34 Million
11,443 Added 72.28%
27,275 $2.31 Million
Q3 2020

Sep 07, 2021

BUY
$90.13 - $108.78 $102,117 - $123,247
1,133 Added 7.71%
15,832 $1.63 Million
Q2 2020

Sep 07, 2021

BUY
$84.11 - $103.33 $183,948 - $225,982
2,187 Added 17.48%
14,699 $1.3 Million
Q1 2020

Sep 07, 2021

SELL
$72.92 - $121.3 $6,416 - $10,674
-88 Reduced 0.7%
12,512 $1.12 Million
Q4 2019

Sep 07, 2021

SELL
$104.49 - $114.54 $19,017 - $20,846
-182 Reduced 1.42%
12,600 $1.43 Million
Q3 2019

Sep 07, 2021

SELL
$98.02 - $111.18 $15,487 - $17,566
-158 Reduced 1.22%
12,782 $1.37 Million
Q2 2019

Sep 07, 2021

SELL
$84.15 - $99.38 $80,615 - $95,206
-958 Reduced 6.89%
12,940 $1.26 Million
Q1 2019

Sep 07, 2021

BUY
$82.45 - $93.79 $53,839 - $61,244
653 Added 4.93%
13,898 $1.27 Million
Q4 2018

Sep 07, 2021

BUY
$85.8 - $99.49 $1,458 - $1,691
17 Added 0.13%
13,245 $1.18 Million
Q3 2018

Sep 07, 2021

BUY
$85.91 - $99.17 $323,451 - $373,375
3,765 Added 39.79%
13,228 $1.3 Million
Q2 2018

Sep 07, 2021

SELL
$77.48 - $87.83 $29,829 - $33,814
-385 Reduced 3.91%
9,463 $810,000
Q1 2018

Sep 07, 2021

BUY
$76.55 - $87.26 $229 - $261
3 Added 0.03%
9,848 $790,000
Q4 2017

Sep 07, 2021

SELL
$76.93 - $83.5 $45,234 - $49,098
-588 Reduced 5.64%
9,845 $795,000
Q3 2017

Sep 07, 2021

SELL
$77.71 - $84.6 $83,926 - $91,368
-1,080 Reduced 9.38%
10,433 $811,000
Q2 2017

Sep 07, 2021

BUY
N/A
138 Added 1.21%
11,513 $1.02 Million
Q1 2017

Sep 07, 2021

BUY
N/A
23 Added 0.2%
11,375 $916,000
Q4 2016

Sep 07, 2021

BUY
N/A
505 Added 4.66%
11,352 $808,000
Q3 2016

Sep 07, 2021

BUY
N/A
843 Added 8.43%
10,847 $937,000
Q2 2016

Sep 07, 2021

SELL
N/A
-205 Reduced 2.01%
10,004 $870,000
Q1 2016

Sep 07, 2021

BUY
N/A
10,209
10,209 $769,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.